Search Results - "Joffe, Hadine"

Refine Results
  1. 1

    Sex and Gender Differences in Health: What the COVID-19 Pandemic Can Teach Us by Spagnolo, Primavera A, Manson, JoAnn E, Joffe, Hadine

    Published in Annals of internal medicine (01-09-2020)
    “…Sex; biological and physiologic traits characterizing males and females; and gender, a continuum of socioculturally constructed roles and behaviors associated…”
    Get full text
    Journal Article
  2. 2

    Vasomotor Symptoms and Menopause: Findings from the Study of Women's Health across the Nation by Thurston, Rebecca C., PhD, Joffe, Hadine, MD, MSc

    “…Vasomotor symptoms (VMS), or hot flashes and night sweats, are often considered the cardinal symptoms of menopause. SWAN, one of the largest and most…”
    Get full text
    Journal Article
  3. 3

    Predictors of increased risk for early treatment non-adherence to oral anti-estrogen therapies in early-stage breast cancer patients by Yusufov, Miryam, Nathan, Margo, Wiley, Aleta, Russell, Julia, Partridge, Ann, Joffe, Hadine

    “…Purpose Non-adherence to the oral anti-estrogen therapies (AET) tamoxifen and aromatase inhibitors in early-stage hormone receptor-positive breast cancer is…”
    Get full text
    Journal Article
  4. 4

    Duration of menopausal vasomotor symptoms over the menopause transition by Avis, Nancy E, Crawford, Sybil L, Greendale, Gail, Bromberger, Joyce T, Everson-Rose, Susan A, Gold, Ellen B, Hess, Rachel, Joffe, Hadine, Kravitz, Howard M, Tepper, Ping G, Thurston, Rebecca C

    Published in JAMA internal medicine (01-04-2015)
    “…The expected duration of menopausal vasomotor symptoms (VMS) is important to women making decisions about possible treatments. To determine total duration of…”
    Get more information
    Journal Article
  5. 5

    Effects of NT-814, a dual neurokinin 1 and 3 receptor antagonist, on vasomotor symptoms in postmenopausal women: a placebo-controlled, randomized trial by Trower, Mike, Anderson, Richard A., Ballantyne, Elizabeth, Joffe, Hadine, Kerr, Mary, Pawsey, Steve

    Published in Menopause (New York, N.Y.) (01-05-2020)
    “…OBJECTIVES:To evaluate the safety, pharmacokinetics, and preliminary efficacy of NT-814, a dual neurokinin 1,3 antagonist, in postmenopausal women with…”
    Get full text
    Journal Article
  6. 6

    Reflections on The Lancet menopause Series – Authors' reply by Hickey, Martha, Hunter, Myra S, Crandall, Carolyn J, Joffe, Hadine, Doust, Jennifer, La Croix, Andrea, Mishra, Gita D, Sivakami, Muthusamy, Brown, Lydia

    Published in The Lancet (British edition) (05-10-2024)
    “…[...]for those at average risk, meaningful fracture prevention would require long-term MHT use, which has associated risks.7 Newer products have been approved…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Menopausal hormone therapy trends before versus after 2002: impact of the Womenʼs Health Initiative Study Results by Crawford, Sybil L, Crandall, Carolyn J, Derby, Carol A, Khoudary, Samar R El, Waetjen, L Elaine, Fischer, Mary, Joffe, Hadine

    Published in Menopause (New York, N.Y.) (21-12-2018)
    “…OBJECTIVE:To better understand how to educate patients and providers about study findings relevant to treatment guidelines, we assessed pre- versus…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Menopausal Vasomotor Symptoms and Risk of Incident Cardiovascular Disease Events in SWAN by Thurston, Rebecca C, Aslanidou Vlachos, Helen E, Derby, Carol A, Jackson, Elizabeth A, Brooks, Maria Mori, Matthews, Karen A, Harlow, Sioban, Joffe, Hadine, El Khoudary, Samar R

    Published in Journal of the American Heart Association (02-02-2021)
    “…Background Cardiovascular disease (CVD) in women has unique features, including associations with reproductive factors that are incompletely understood…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Sleep During the Perimenopause: A SWAN Story by Kravitz, Howard M., DO, MPH, Joffe, Hadine, MD, MSc

    “…Is there evidence for a perimenopausal sleep disorder? We address this question in our presentation of the Study of Women's Health Across the Nation (SWAN)…”
    Get full text
    Journal Article
  14. 14

    Vasomotor symptoms in midlife women with incident breast cancer: pink SWAN by Gold, Ellen B., Crawford, Sybil L., Leung, Katherine, Greendale, Gail, Reeves, Katherine W., Joffe, Hadine, Avis, Nancy E.

    Published in Breast cancer research and treatment (01-01-2022)
    “…Purpose We compared trajectories of vasomotor symptoms (VMS) and their risk factors in women with breast cancer (BrCa) to those of cancer-free controls…”
    Get full text
    Journal Article
  15. 15

    Vasomotor Symptoms and Insulin Resistance in the Study of Women's Health Across the Nation by Thurston, Rebecca C, El Khoudary, Samar R, Sutton-Tyrrell, Kim, Crandall, Carolyn J, Sternfeld, Barbara, Joffe, Hadine, Gold, Ellen B, Selzer, Faith, Matthews, Karen A

    “…Context: Emerging research suggests links between menopausal hot flashes and cardiovascular disease risk. The mechanisms underlying these associations are…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Longitudinal Association Between Depressive Symptoms and Multidimensional Sleep Health: The SWAN Sleep Study by Bowman, Marissa A, Kline, Christopher E, Buysse, Daniel J, Kravitz, Howard M, Joffe, Hadine, Matthews, Karen A, Bromberger, Joyce T, Roecklein, Kathryn A, Krafty, Robert T, Hall, Martica H

    Published in Annals of behavioral medicine (28-06-2021)
    “…Abstract Background Depressive symptoms and sleep disturbances disproportionately affect midlife women. While there may be a bidirectional association, few…”
    Get full text
    Journal Article
  18. 18

    Plasma androgens and the presence and course of depression in a large cohort of women by de Wit, Anouk E., Giltay, Erik J., de Boer, Marrit K., Bosker, Fokko J., Cohn, Aviva Y., Nolen, Willem A., Kaiser, Ursula B., Joffe, Hadine, Penninx, Brenda W.J.H., Schoevers, Robert A.

    Published in Translational psychiatry (12-02-2021)
    “…Major depressive disorder (MDD) has a higher prevalence in women with supraphysiologic androgen levels. Whether there is also an association between depression…”
    Get full text
    Journal Article
  19. 19

    The Impact of Depot GnRH Agonist on AMH Levels in Healthy Reproductive-Aged Women by Su, H. Irene, Maas, Kevin, Sluss, Patrick M, Chang, R. Jeffrey, Hall, Janet E, Joffe, Hadine

    “…Context: GnRH agonists (GnRHa) are being used experimentally in an attempt to preserve fertility in young female cancer patients undergoing chemotherapy…”
    Get full text
    Journal Article
  20. 20